S. Byford, D. Torgerson, and J. Raftery, Economic Note: Cost of illness studies, BMJ, vol.320, issue.7245, p.1335, 2000.
DOI : 10.1136/bmj.320.7245.1335

M. Koopmanschap, Cost-of-Illness Studies, PharmacoEconomics, vol.14, issue.2, pp.143-148, 1998.
DOI : 10.2165/00019053-199814020-00001

T. Hogdson, Annual costs of illness versus Lifetime costs of illness and implications of structural change, Drug Inf J, vol.22, pp.323-341, 1988.

A. Wimo and M. Prince, The global Economic Impact of Dementia, World Alzheimer Report Alzheimer Disease Int, pp.1-52, 2010.

O. Brien, B. Goeree, R. Hux, M. Iskedjian, M. Blackhouse et al., Economic Evaluation of Donepezil for the Treatment of Alzheimer's Disease in Canada, Journal of the American Geriatrics Society, vol.266, issue.5, pp.570-578, 1999.
DOI : 10.1111/j.1532-5415.1999.tb02572.x

J. Hill, R. Futterman, V. Mastey, and H. Fillit, The effect of donepezil therapy on health costs in a Medicare managed plan, Manag Care Interface, vol.15, issue.3, pp.63-70, 2002.

L. Jönsson and A. Wimo, The Cost of Dementia in Europe, PharmacoEconomics, vol.16, issue.4, pp.391-403, 2009.
DOI : 10.2165/00019053-200927050-00004

J. Mauskopf and L. Mucha, A Review of the Methods Used to Estimate the Cost of Alzheimer???s Disease in the United States, American Journal of Alzheimer's Disease & Other Dementias??, vol.14, issue.8, pp.298-309, 2011.
DOI : 10.1177/1533317511407481

D. Mcdaid, Estimating the costs of informal care for people with Alzheimer's disease: methodological and practical challenges, International Journal of Geriatric Psychiatry, vol.14, issue.4, pp.400-405, 2001.
DOI : 10.1002/gps.353

M. Drummond, Methods for the economic evaluation of health care programmes, 2005.

L. Molinier, E. Bauvin, C. Combescure, C. Castelli, X. Rebillard et al., Methodological Considerations in Cost of Prostate Cancer Studies: A Systematic Review, Value in Health, vol.11, issue.5, pp.878-885, 2008.
DOI : 10.1111/j.1524-4733.2008.00327.x

J. Lopez-bastida, P. Serrano-aguilar, L. Perestelo-perez, and J. Oliva-moreno, Socialeconomic costs and quality of life of Alzheimer disease in the Canary Islands, Spain, Neurology, vol.2667, issue.12, pp.2186-2191, 2006.

A. Coduras, I. Rabasa, A. Frank, F. Bermejo-pareja, S. López-pousa et al., Prospective One-Year Cost-of-Illness Study in a Cohort of Patients with Dementia of Alzheimer's Disease Type in Spain: The ECO Study, Journal of Alzheimer's Disease, vol.19, issue.2, pp.601-615, 2010.
DOI : 10.3233/JAD-2010-1258

A. Rigaud, F. Fagnani, C. Bayle, F. Latour, and L. Traykov, Patients with Alzheimer's Disease Living at Home in France: Costs and Consequences of the Disease, Journal of Geriatric Psychiatry and Neurology, vol.16, issue.3, pp.140-145, 2003.
DOI : 10.1177/0891988703252558

K. Andersen, C. Søgaard, J. Hansen, E. Kragh-sørensen, A. Hastrup et al., The Cost of Dementia in Denmark: The Odense Study, Dementia and Geriatric Cognitive Disorders, vol.10, issue.4, pp.295-304, 1999.
DOI : 10.1159/000017135

M. Cavallo and G. Fattore, The economic and social burden of Alzheimer disease on families in the Lombardy region of Italy, Alzheimer Dis Assoc Disord, vol.11, issue.4, pp.184-190, 1997.

J. Mesterton, A. Wimo, A. By, S. Langworth, B. Winblad et al., Cross Sectional Observational Study on the Societal Costs of Alzheimers Disease, Current Alzheimer Research, vol.7, issue.4, pp.358-367, 2010.
DOI : 10.2174/156720510791162430

P. Kiencke, D. Dietmar, C. Grimm, and R. Rychlik, Direct costs of Alzheimer???s disease in Germany, The European Journal of Health Economics, vol.21, issue.5, pp.533-539, 2011.
DOI : 10.1007/s10198-010-0267-x

J. Leon and P. Neumann, The cost of Alzheimer's disease in managed care: a cross-sectional study, Am J Manag Care, vol.5, issue.7, pp.867-877, 1999.

J. Hay and R. Ernst, The economic costs of Alzheimer's disease., American Journal of Public Health, vol.77, issue.9, pp.1169-1175, 1987.
DOI : 10.2105/AJPH.77.9.1169

D. Rice, P. Fox, M. W. Webber, P. Lindeman, D. Hauck et al., The economic burden of Alzheimer's disease care, Health Affairs, vol.12, issue.2, pp.164-176, 1993.
DOI : 10.1377/hlthaff.12.2.164

J. Leon, C. Cheng, and P. Neumann, Alzheimer's disease care: costs and potential savings, Health Affairs, vol.17, issue.6, pp.206-216, 1998.
DOI : 10.1377/hlthaff.17.6.206

T. Ostbye and E. Crosse, Net economic costs of dementia in Canada, CMAJ, vol.15151, issue.10, pp.1457-1464, 1994.

M. Zencir, N. Kuzu, N. Be?er, A. Ergin, B. Catak et al., Cost of Alzheimer's disease in a developing country setting, International Journal of Geriatric Psychiatry, vol.27, issue.7, pp.616-622, 2005.
DOI : 10.1002/gps.1332

G. Wang, Q. Cheng, S. Zhang, L. Bai, J. Zeng et al., Economic Impact of Dementia in Developing Countries: An Evaluation of Alzheimer-Type Dementia in Shanghai, China, Journal of Alzheimer's Disease, vol.15, issue.1, pp.109-115, 2008.
DOI : 10.3233/JAD-2008-15109

G. Suh, M. Knapp, and C. Kang, The economic costs of dementia in Korea, 2002, International Journal of Geriatric Psychiatry, vol.12, issue.8, pp.722-728, 2002.
DOI : 10.1002/gps.1552

M. Beeri, P. Werner, Z. Adar, M. Davidson, and S. Noy, Economic Cost of Alzheimer Disease in Israel, Alzheimer Disease & Associated Disorders, vol.16, issue.2, pp.73-80, 2002.
DOI : 10.1097/00002093-200204000-00004

R. Allegri, J. Butman, R. Arizaga, G. Machnicki, C. Serrano et al., Economic impact of dementia in developing countries: an evaluation of costs of Alzheimer-type dementia in Argentina, International Psychogeriatrics, vol.19, issue.04, pp.705-718, 2007.
DOI : 10.1017/S1041610206003784

G. Mckhann, D. Drachman, M. Folstein, R. Katzman, D. Price et al., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, issue.7, pp.34939-944, 1984.

W. Quentin, S. Riedel-heller, M. Luppa, A. Rudolph, and H. König, Cost-of-illness studies of dementia: a systematic review focusing on stage dependency of costs, Acta Psychiatrica Scandinavica, vol.12, issue.suppl. 1, pp.243-259, 2010.
DOI : 10.1111/j.1600-0447.2009.01461.x

G. Small, D. Mcdonnell, R. Brooks, and G. Papadopoulos, The Impact of Symptom Severity on the Cost of Alzheimer's Disease, Journal of the American Geriatrics Society, vol.55, issue.2, pp.321-327, 2002.
DOI : 10.1016/0895-4356(95)00507-2

J. Mauskopf, J. Racketa, and E. Sherrill, Alzheimer's disease: The strength of association of costs with different measures of disease severity, The journal of nutrition, health & aging, vol.27, issue.2, pp.655-663, 2010.
DOI : 10.1007/s12603-010-0312-6

N. Herman, D. Tam, R. Balshaw, R. Sambrook, N. Lesnikova et al., Canadian Outcomes Study in Dementia [COSID] Investigators, The relation between disease severity and cost of caring for patients with Alzheimer disease in Canada, Can J Psychiatry, issue.12, pp.55768-775, 2010.

J. Morris, The Clinical Dementia Rating (CDR): Current version and scoring rules, Neurology, vol.43, issue.11, pp.2412-2414, 1983.
DOI : 10.1212/WNL.43.11.2412-a

R. Crum, J. Anthony, S. Bassett, and M. Folstein, Population-Based Norms for the Mini-Mental State Examination by Age and Educational Level, JAMA: The Journal of the American Medical Association, vol.269, issue.18, pp.2386-2389, 1993.
DOI : 10.1001/jama.1993.03500180078038

C. Zhu, N. Scarmeas, R. Torgan, M. Albert, J. Brandt et al., Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease, Neurology, vol.67, issue.6, pp.998-1005, 2006.
DOI : 10.1212/01.wnl.0000230160.13272.1b

R. Tarricone, Cost-of-illness analysis, Health Policy, vol.77, issue.1, pp.51-63, 2006.
DOI : 10.1016/j.healthpol.2005.07.016

M. Koopmanschap and F. Rutten, Indirect Costs in Economic Studies, PharmacoEconomics, vol.4, issue.6, pp.446-454, 1993.
DOI : 10.2165/00019053-199304060-00006

M. Koopmanschap and B. Van-ineveld, Towards a new approach for estimating indirect costs of disease, Social Science & Medicine, vol.34, issue.9, pp.1005-1010, 1992.
DOI : 10.1016/0277-9536(92)90131-9

T. Hogdson and M. Meiners, Cost of illness methodology a guide to current practices and procedures. Milbank Mem Fund Q Health Soc, pp.429-462, 1982.

B. Van-der-berg, W. Brouwer, J. Van-exel, M. Koopmanschap, G. Van-den-bos et al., Economic valuation of informal care: Lessons from the application of the opportunity costs and proxy good methods, Social Science & Medicine, vol.62, issue.4, pp.835-845, 2006.
DOI : 10.1016/j.socscimed.2005.06.046

M. Koopmanschap, V. Exel, J. Van-den-berg, B. Brouwer, and W. , An Overview of Methods and Applications to Value Informal Care in Economic Evaluations of Healthcare, PharmacoEconomics, vol.18, issue.1, pp.269-280, 2008.
DOI : 10.2165/00019053-200826040-00001

M. Gold, L. Russel, J. Siegel, N. Daniels, and M. Weinstein, Cost effectiveness in Health and Medicine, JAMA, vol.276, issue.14, pp.1172-1177, 1996.

K. Agro, C. Bradley, and N. Mittmann, Sensitivity Analysis in Health Economic and Pharmacoeconomic Studies, PharmacoEconomics, vol.11, issue.1, pp.75-88, 1997.
DOI : 10.2165/00019053-199711010-00009

V. Wiseman and G. Mooney, SOUNDING BOARD, Health Policy, vol.43, issue.3, pp.243-251, 1998.
DOI : 10.1016/S0168-8510(98)00003-7

A. Wimo, G. Nordberg, W. Jansson, and M. Grafström, Assessment of informal services to demented people with the RUD instrument, International Journal of Geriatric Psychiatry, vol.34, issue.10, pp.969-971, 2000.
DOI : 10.1002/1099-1166(200010)15:10<969::AID-GPS272>3.0.CO;2-9

K. Davis, D. Marin, R. Kane, D. Patrick, E. Peskind et al., The Caregiver Activity Survey (CAS): development and validation of a new measure for caregivers of persons with Alzheimer's disease, International Journal of Geriatric Psychiatry, vol.29, issue.10, pp.12978-988, 1997.
DOI : 10.1002/(SICI)1099-1166(199710)12:10<978::AID-GPS659>3.0.CO;2-1

E. Clipp and M. Moore, Caregiver time use: An outcome measure in clinical trial research on Alzheimer's disease*, Clinical Pharmacology & Therapeutics, vol.11, issue.2, pp.228-236, 1995.
DOI : 10.1016/0009-9236(95)90201-5

J. Segel, Cost-of-Illness studies-A primer, RTI -UNC Center of Excellence in Health Promotion Economics. RTI international World Bank: World Bank -list economies.Country and lending groups, pp.1-39, 2006.

P. Schreyer and F. Koechlin, Purchasing power parities: measurement and uses, Statistics breaf. OECD Statistics, vol.3, pp.1-8, 2002.